Clinical Trials Browser

Phase 1/2 × pazopanib × Other solid neoplasm × Clear all

NCT06895733 2025-03-26

Study of Pazopanib Combined With Palbociclib for Refractory Solid Tumors With Co-amplified in the 11q13(FGF3/4/19/CCND1)

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT02303028 2022-06-28

TOPAZ

Phase 1/2 Completed

Other solid neoplasm

Solid Tumors

NCT03628131 2018-09-19

Combination Chemotherapy With Pazopanib in Children and Adolescents With Relapsed/Refractory Solid Tumors

Phase 1/2 Unknown

Other solid neoplasm

Relapsed Pediatric Solid Tumor